Joseph Romanelli - Apr 29, 2025 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
President, Human Health Int?l
Signature
/s/ Kelly E. W. Grez, attorney-in-fact for Joseph Romanelli
Stock symbol
MRK
Transactions as of
Apr 29, 2025
Transactions value $
$0
Form type
4
Date filed
5/1/2025, 05:43 PM
Previous filing
Jan 6, 2025
Next filing
May 2, 2025
SEC
View on sec.gov
This filing has been restated, see here for the amended filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MRK Common Stock 21.8K Apr 29, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Restricted Stock Unit Award $0 +4.72K $0.00 4.72K Apr 29, 2025 Common Stock 4.72K Direct F2, F3
transaction MRK Restricted Stock Unit Award $0 +9.44K $0.00 9.44K Apr 29, 2025 Common Stock 9.44K Direct F2, F3
transaction MRK Stock Option (Right to Buy) Award $0 +21.5K $0.00 21.5K Apr 29, 2025 Common Stock 21.5K $84.71 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings include shares acquired in dividend reinvestment transactions.
F2 Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F3 These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.
F4 The option vests and becomes exercisable in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.